Thalmann, George N <br/><br/>
Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.  [electronic resource] 

 -  The Journal of urology  Oct 2002 
 - 1381-5 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>0022-5347 
<br/><br/><label>Standard No.: </label>10.1016/S0022-5347(05)64454-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>BCG Vaccine--therapeutic use<br/>Carcinoma in Situ--drug therapy<br/>Carcinoma, Transitional Cell--drug therapy<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Neoplasm Staging<br/>Nephrectomy<br/>Nephrostomy, Percutaneous<br/>Perfusion<br/>Retrospective Studies<br/>Survival Rate<br/>Ureter--pathology<br/>Ureteral Neoplasms--drug therapy<br/>Urinary Bladder Neoplasms--drug therapy<br/>Urinary Diversion